Yoshikane Kikushige

10PUBLICATIONS
26CO-AUTHORS
Molecular targetsGene and molecular therapyInstruments and techniquesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 22, 2025
KK2845, a PBD dimer-containing antibody-drug conjugate targeting TIM-3-expressing AML.

Jian Zou, Haruka Kinosada, Shin-Ichiro Takayanagi

|Dec 27, 2024
TIM-3 marks measurable residual leukemic stem cells responsible for relapse after allogeneic stem cell transplantation.

Teppei Sakoda, Yoshikane Kikushige, Hidetoshi Irifune

|May 24, 2024
Immunology and targeted therapy in Castleman disease.

Shinichiro Tsunoda, Takuya Harada, Yoshikane Kikushige

Pageof 2